Howe & Rusling Inc Syros Pharmaceuticals, Inc. Transaction History

Howe & Rusling Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 04, 2019	SELL	$5.55 - $11.34 $277 - $567	-50 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$9.74 - $12.92 $974 - $1,292	-100 Reduced 66.67%	50 $1,000
Q1 2018 May 14, 2018	BUY	$9.47 - $12.98 $473 - $649	50 Added 50.0%	150 $2,000
Q4 2017 Jan 24, 2018	BUY	$8.45 - $17.48 $844 - $1,748	100	100 $1,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.